BICCIATO, Silvio
 Distribuzione geografica
Continente #
NA - Nord America 26.717
EU - Europa 11.248
AS - Asia 8.736
SA - Sud America 1.633
AF - Africa 156
OC - Oceania 56
Continente sconosciuto - Info sul continente non disponibili 11
Totale 48.557
Nazione #
US - Stati Uniti d'America 26.447
GB - Regno Unito 3.487
IT - Italia 3.215
CN - Cina 2.854
SG - Singapore 2.498
HK - Hong Kong 1.440
BR - Brasile 1.275
SE - Svezia 1.062
DE - Germania 782
VN - Vietnam 544
UA - Ucraina 509
RU - Federazione Russa 503
TR - Turchia 376
FR - Francia 367
FI - Finlandia 329
ID - Indonesia 256
NL - Olanda 256
KR - Corea 230
BG - Bulgaria 229
IN - India 133
CA - Canada 113
AR - Argentina 109
JP - Giappone 95
EC - Ecuador 82
MX - Messico 82
CO - Colombia 68
ZA - Sudafrica 60
IE - Irlanda 59
PL - Polonia 59
BD - Bangladesh 54
AT - Austria 51
ES - Italia 51
BE - Belgio 46
IQ - Iraq 46
LT - Lituania 38
AU - Australia 34
IR - Iran 34
CH - Svizzera 28
CL - Cile 27
CZ - Repubblica Ceca 27
RO - Romania 26
PA - Panama 24
PE - Perù 22
PT - Portogallo 22
PY - Paraguay 22
TW - Taiwan 20
NZ - Nuova Zelanda 19
VE - Venezuela 18
AE - Emirati Arabi Uniti 17
MA - Marocco 17
PK - Pakistan 17
EG - Egitto 16
GR - Grecia 16
SI - Slovenia 15
DK - Danimarca 13
PH - Filippine 12
UZ - Uzbekistan 12
BZ - Belize 11
KE - Kenya 11
TN - Tunisia 11
DZ - Algeria 10
IL - Israele 10
DO - Repubblica Dominicana 9
SK - Slovacchia (Repubblica Slovacca) 9
TH - Thailandia 9
LU - Lussemburgo 8
TZ - Tanzania 8
JM - Giamaica 7
JO - Giordania 7
KZ - Kazakistan 7
MY - Malesia 7
OM - Oman 7
RS - Serbia 7
SA - Arabia Saudita 7
CR - Costa Rica 6
UY - Uruguay 6
AM - Armenia 5
AZ - Azerbaigian 5
BY - Bielorussia 5
EU - Europa 5
KG - Kirghizistan 5
LB - Libano 5
MD - Moldavia 5
TT - Trinidad e Tobago 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
ET - Etiopia 4
HN - Honduras 4
LV - Lettonia 4
NI - Nicaragua 4
NO - Norvegia 4
PS - Palestinian Territory 4
AO - Angola 3
BH - Bahrain 3
BO - Bolivia 3
EE - Estonia 3
HU - Ungheria 3
NG - Nigeria 3
NP - Nepal 3
SC - Seychelles 3
Totale 48.516
Città #
Fairfield 3.689
Southend 2.403
Ashburn 2.311
Santa Clara 2.112
Woodbridge 1.886
Singapore 1.569
Chandler 1.536
Houston 1.511
Hong Kong 1.416
Seattle 1.399
Cambridge 1.270
Wilmington 1.214
Ann Arbor 1.003
Jacksonville 927
Hefei 909
Dearborn 890
Nyköping 637
London 626
Beijing 604
San Diego 339
Modena 315
Los Angeles 287
Milan 267
Chicago 266
Princeton 258
Izmir 247
Sofia 224
Jakarta 220
Council Bluffs 218
Seoul 205
The Dalles 204
Des Moines 200
Eugene 184
New York 181
Ho Chi Minh City 179
Rome 160
Helsinki 149
Buffalo 127
Moscow 127
Shanghai 118
Hanoi 101
São Paulo 97
Salt Lake City 95
Phoenix 89
Redwood City 86
Munich 78
Falls Church 76
Dong Ket 75
Columbus 73
Bologna 68
Dallas 68
Berlin 63
Bremen 61
Boardman 60
Tokyo 54
Guangzhou 52
Florence 51
Padova 51
Palermo 51
Dublin 48
Verona 48
Norwalk 47
San Jose 47
Elk Grove Village 46
Rio de Janeiro 44
Toronto 44
Frankfurt am Main 42
Naples 42
Tampa 42
Brussels 41
Kent 41
Nanjing 36
Redondo Beach 36
Grafing 35
Nuremberg 35
Sterling 35
Bari 34
Turin 33
Brasília 32
Cardiff 32
Quito 31
Parma 29
San Francisco 29
Amsterdam 28
Charlotte 28
Miami 28
Warsaw 27
Denver 26
Kunming 25
Chennai 24
Haiphong 24
Johannesburg 24
Perugia 24
Belo Horizonte 23
Brooklyn 23
Jinan 23
Lancaster 23
Montreal 23
Ottawa 22
Paris 22
Totale 35.082
Nome #
Role of YAP/TAZ in mechanotransduction 824
Matrici di DNA per lo studio dell’espressione genica 789
Genomica e proteomica computazionale 722
Analisi di dati di DNA microarray: fondamenti, selezione di geni, classificazione 616
Regeneration of the entire human epidermis using transgenic stem cells 585
Exome sequencing and bioinformatic approaches reveals rare sequence variants involved in cell signalling and elastic fibre homeostasis: new evidence in the development of ectopic calcification 452
MafB is a downstream target of the IL-10/STAT3 signaling pathway, involved in the regulation of macrophage de-activation 353
Comparison of computational methods for Hi-C data analysis 347
MDP, a database linking drug response data to genomic information, identifies dasatinib and statins as a combinatorial strategy to inhibit YAP/TAZ in cancer cells 342
Computational methods for analyzing genome-wide chromosome conformation capture data 332
A locally adaptive statistical procedure (LAP) to identify differentially expressed chromosomal regions 327
UCbase 2.0: ultraconserved sequences database (2014 update) 325
Aerobic glycolysis tunes YAP/TAZ transcriptional activity 325
Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma 321
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 319
Genomic expression during human myelopoiesis 317
APTANI2: Update of aptamer selection through sequence-structure analysis 312
Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression 311
IL-7 and IL-15 instruct the generation of human memory stem T cells from naïve precursors 310
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 305
Algorithm for automatic genotype calling of single nucleotide polymorphisms using the full course of TaqMan real-time data 293
Dynamic Transcriptional and Epigenetic Regulation of Human Epidermal Keratinocyte Differentiation 293
YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response. 291
Chromosome positioning in interphase nuclei of hematopoietic stem cell and myeloid precursor 285
Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation 285
Single-cell analyses reveal YAP/TAZ as regulators of stemness and cell plasticity in glioblastoma 284
Transcriptional addiction in cancer cells is mediated by YAP/TAZ through BRD4 280
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoiesis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 275
A MicroRNA targeting dicer for metastasis control 274
APTANI: a computational tool to select aptamers through sequence-structure motif analysis of HT-SELEX data 272
A comparative transcriptomic analysis of astrocytes differentiation from human neural progenitor cells 271
A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis 270
Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy 269
Mining of Biological Data I: Identifying Discriminating Features via Mean Hypothesis Testing 268
Glucocorticoid receptor signalling activates YAP in breast cancer 268
A-MADMAN: annotation-based microarray data meta-analysis tool. 262
Integrative genomic analysis reveals distinct transcriptional and genetic features associated with chromosome 13 deletion in multiple myeloma 262
HGM 2010 Programme / Abstract 259
Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment 259
A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients 258
Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferation 257
The calcineurin-NFAT pathway controls activity-dependent circadian gene expression in slow skeletal muscle 255
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth 254
Molecular characterization of human multiple myeloma cell lines by integrative genomics: Insights into the biology of the disease 253
Genome-wide definition of promoter and enhancer usage during neural induction of human embryonic stem cells 253
Acute Leukemia Subclassification: A Marker Protein Expression Perspective 251
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 247
Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients 247
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells 246
Comparative genomics revealed key molecular targets to rapidly convert a reference rifamycin-producing bacterial strain into an overproducer by genetic engineering 246
A computational procedure to identify significant overlap of differentially expressed and genomic imbalanced regions in cancer datasets. 245
Transcriptional profiling of human bronchial epithelial cell BEAS-2B exposed to diesel and biomass ultrafine particles 245
A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer 245
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer 244
Aging: A portrait from gene expression profile in blood cells 244
Immunophenotype signature as a tool to define prognostic subgroups in childhood acute myeloid leukemia 243
SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors 243
Computational analysis of flow-cytometry antigen expression profiles in childhood acute lymphoblastic leukemia: an MLL/AF4 identification 241
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-miR-299-5p in CD34+ progenitor cells commitment 241
Reprogramming normal cells into tumour precursors requires ECM stiffness and oncogene-mediated changes of cell mechanical properties 241
Extracellular matrix mechanical cues regulate lipid metabolism through Lipin-1 and SREBP 240
Induction of Expandable Tissue-Specific Stem/Progenitor Cells through Transient Expression of YAP/TAZ 239
Dynamics of cellular states of fibro-adipogenic progenitors during myogenesis and muscular dystrophy 238
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells 237
Notch is a direct negative regulator of the DNA-damage response 237
A gene expression signature associated with survival in metastatic melanoma 236
High NRF2 levels correlate with poor prognosis in colorectal cancer patients and with sensitivity to the kinase inhibitor AT9283 in vitro 236
Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells 236
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 235
A multifactorial ‘Consensus Signature’ by in silico analysis to predict response to neoadjuvant anthracycline-based chemotherapy in triple-negative breast cancer 235
Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma 233
Identification of new genomic lesions in childhood ALL without known genetic aberrations: A microarray study of gene expression and genotype data. 232
Molecular classification of multiple myeloma: A distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations 232
LncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome 232
Gene expression profiling of human fibrocytic myeloid-derived suppressor cells (f-MDSCs) 231
Muscle insulin sensitivity and glucose metabolism are controlled by the intrinsic muscle clock. 231
Allele specific CRISPR/Cas9 editing of dominant Epidermolysis Bullosa Simplex in human epidermal stem cells 230
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 230
Critical analysis of transcriptional and post-transcriptional regulatory networks in multiple myeloma 229
P2X7 receptor restrains pathogenic Tfh cell generation in systemic lupus erythematosus 229
F-actin dynamics regulates mammalian organ growth and cell fate maintenance 229
Aryl hydrocarbon receptor control of a disease tolerance defence pathway 228
YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins 228
Pattern identification and classification in gene expression data using an autoassociative neural network model 227
Identifying Seismicity Patterns Leading Flank Eruptions at Mt. Etna Volcano During 1981-1996 225
Toward the identification of a tolerogenic signature in IDO-competent dendritic cells 225
Mining of Biological Data II: Assessing Data Structure and Class Homogeneity by Cluster Analysis 225
Mechanical cues control mutant p53 stability through a mevalonate-RhoA axis 224
GDA, a web-based tool for Genomics and Drugs integrated analysis 220
TRANSCRIPTOME ANALYSIS IN THE INTERACTION BRACHYPODIUM – PUCCINIA BRACHYPODII 218
Transcriptional features of multiple myeloma patients with chromosome 1q gain 214
Novel definition files for human GeneChips based on GeneAnnot 214
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8(+) T cells 213
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis 213
PCA disjoint models for multiclass cancer analysis using gene expression data 211
Impact of probe annotation on the integration of miRNA-mRNA expression profiles for miRNA target detection 211
Role of TAZ as Mediator of Wnt Signaling 211
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 211
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 211
MRF4 negatively regulates adult skeletal muscle growth by repressing MEF2 activity 210
Totale 27.999
Categoria #
all - tutte 199.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 199.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.949 0 0 0 0 0 404 633 731 306 881 497 497
2021/20224.971 406 547 489 240 136 432 263 286 505 427 705 535
2022/20234.530 533 432 384 383 508 762 102 450 558 64 186 168
2023/20243.015 142 172 211 227 471 270 247 391 115 152 139 478
2024/20259.007 335 97 116 577 1.694 1.233 611 635 944 677 1.063 1.025
2025/20267.838 1.124 738 1.619 1.827 2.081 449 0 0 0 0 0 0
Totale 49.112